What is Aculabs?
Aculabs, Inc. is a full-service laboratory with over 35 years of experience providing superior quality diagnostic testing. The company's mission centers on excellence, leveraging its medical and scientific expertise to deliver accurate diagnostic information efficiently. Aculabs is equipped with state-of-the-art instrumentation for a wide range of routine and esoteric tests, supported by extensive computerization for client services, online test requests, and real-time result review. Their professional staff and consultants bring decades of combined experience in hospital, research, and independent laboratory settings, with a commitment to innovation in diagnosis to positively impact patient therapy and prognosis. The laboratory is fully accredited and participates in Medicare and Medicaid programs across New Jersey, Pennsylvania, Delaware, and Maryland, holding licenses from relevant state health departments and excelling in the College of American Pathologists' stringent proficiency testing program.
How much funding has Aculabs raised?
Aculabs has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Aculabs
PPP
Public-Private Partnership
What's next for Aculabs?
The recent major strategic investment into Aculabs signals a pivotal moment for the company, likely enabling further expansion of its diagnostic capabilities and technological infrastructure. This capital infusion is expected to fuel advancements in their testing menu, potentially including more esoteric assays, and enhance their existing computerization efforts for improved client services. Given the enterprise-level context of this funding, Aculabs is poised to solidify its market position and continue its trajectory of providing high-quality, innovative diagnostic solutions to healthcare providers, reinforcing its commitment to patient care and scientific advancement.
See full Aculabs company page
